Surgical valve technologies

Surgical treatment of patients with infective endocarditis: changes in temporal use, patient characteristics, and mortality—a nationwide study

Published on 18/08/2022 | Jensen Andreas Dalsgaard 1 et al. | BMC Cardiovascular Disorders 2022; 22(1): 338 | 24 minute read

Abstract Background Valve surgery guidelines for infective endocarditis (IE) are unchanged over decades and nationwide data about the use of

Surgical valve technologies

Redefining “low risk”: Outcomes of surgical aortic valve replacement in low-risk patients in the transcatheter aortic valve replacement era

Published on 04/08/2022 | Johnston et al. | The Journal of thoracic and cardiovascular surgery 2022; aop:10.1016/j.jtcvs.2021.01.145 | 0 minute read

Surgical valve technologies

Effect of β‐blocker on patients with moderate functional mitral regurgitation undergoing surgical aortic valve replacement

Published on 04/08/2022 | Xieraili Tiemuerniyazi et al. | ESC heart failure 2022; AOP: 10.1002/ehf2.14053 | 20 minute read

Abstract Aims The optimal treatment for severe aortic valve disease complicated with moderate function mitral regurgitation (FMR) remains controversial. Although

Surgical valve technologies

Surgical treatment of isolated tricuspid valve endocarditis: Midterm data

Published on 21/07/2022 | Elda DzilicMD 1 et al. | Journal of Cardiac Surgery 2022; AOP: 10.1111/jocs.16741 | 14 minute read

Abstract Background Isolated tricuspid valve endocarditis (TVE) is a rare disease which is managed medically in most patients. Only in

Surgical valve technologies

Mitral valve repair versus replacement in patients with rheumatic heart disease

Published on 07/07/2022 | Chen et al. | The Journal of thoracic and cardiovascular surgery 2022; 164(1): 57-67.e11 | 0 minute read

Surgical valve technologies

Outcomes of aortic root enlargement during isolated aortic valve replacement

Published on 07/07/2022 | Emily ShihMD 1 et al. | Journal of Cardiac Surgery 2022; AOP: 10.1111/jocs.16645 | 13 minute read

Abstract Objectives Aortic root enlargement (ARE) lowers the risk of patient prosthesis mismatch after surgical aortic valve replacement (SAVR) in

Surgical valve technologies

A retrospective study on the trends in surgical aortic valve replacement outcomes in the post‐transcatheter aortic valve replacement era

Published on 16/06/2022 | Johnny Chahine 1 et al. | Health Science Reports 2022; 5(3): 660 | 15 minute read

Abstract Background and Aims Transcatheter aortic valve replacement (TAVR) is the mainstay of treatment of inoperable and severe high‐risk aortic

Surgical valve technologies

Influence of surgical volume on outcomes in low-risk patients undergoing isolated surgical aortic valve replacement

Published on 02/06/2022 | Dewey et al. | The Journal of thoracic and cardiovascular surgery 2022; 163(6): 2046-2052.e2 | 0 minute read

Surgical valve technologies

Surgical aortic valve replacement for low-gradient aortic stenosis

Published on 02/06/2022 | Brega et al. | Journal of Cardiovascular Medicine 2022; 23(5): 338-43 | 14 minute read

Abstract Aims Low-gradient aortic stenosis is a challenging entity that needs accurate preoperative evaluation. For this high-risk patient population, ad

Surgical valve technologies

Long-term outcome of extensive mitral valve reconstruction with autologous pericardium and artificial chordae for treatment of destructive active infective endocarditis of the mitral valve

Published on 19/05/2022 | Handa Kazuma et al. | Journal of Cardiothoracic Surgery 2022; 17(1): 97 | 15 minute read

Abstract Objective Mitral valve (MV) repair is a well-accepted surgical approach for infective endocarditis (IE). In our hospital, extensive MV

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.